Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q2 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.